Chromosomal microarray analysis (CMA) is a genome-wide assay that examines the chromosomes for tiny, sub-microscopic deletions or duplications of DNA sequences, known as copy-number variants.

WESTCHESTER, N. Y. -- A new test, called chromosomal microarray technology, is providing doctors and prospective parents with more information than ever before about the genetic makeup of a baby ...

The test, called a chromosomal microarray, detected more irregularities that could result in genetic diseases — such as missing or repeated sections of genetic code — than did karyotyping ...

CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray ...

An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray as the new standard practice for genetic evaluation of children with ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

In this regard, the microarray platform is perfectly suited for inclusion in testing approaches that leverage panels that can, for example, identify key genetic factors involved in a particular ...

They reviewed demographics, medical and neuropsychological characteristics and genetic test results. Genetic testing for ASD includes chromosomal microarray (CMA) and fragile X. “In terms of the rate ...

In cases of large-scale genomic gains, adjunct metaphase FISH analysis can be used to visualize the precise chromosomal location of the extra genetic material identified by microarray.